MWG Management
Latest statistics and disclosures from MWG Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BEAM, LYEL, PRME, and represent 100.00% of MWG Management's stock portfolio.
- MWG Management has $103M in assets under management (AUM), dropping by -37.58%.
- Central Index Key (CIK): 0001845151
Tip: Access up to 7 years of quarterly data
Positions held by MWG Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for MWG Management
MWG Management holds 3 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Beam Therapeutics (BEAM) | 54.7 | $56M | 2.3M | 24.05 |
|
|
| Lyell Immunopharma (LYEL) | 28.7 | $30M | 20M | 1.47 |
|
|
| Prime Medicine (PRME) | 16.6 | $17M | 1.8M | 9.54 |
|
Past Filings by MWG Management
SEC 13F filings are viewable for MWG Management going back to 2020
- MWG Management 2023 Q3 filed Nov. 14, 2023
- MWG Management 2023 Q2 filed Aug. 14, 2023
- MWG Management 2023 Q1 filed May 15, 2023
- MWG Management 2022 Q4 filed Feb. 14, 2023
- MWG Management 2022 Q3 filed Nov. 14, 2022
- MWG Management 2022 Q2 filed Aug. 15, 2022
- MWG Management 2022 Q1 filed May 16, 2022
- MWG Management 2021 Q4 filed Feb. 14, 2022
- MWG Management 2021 Q3 filed Nov. 15, 2021
- MWG Management 2021 Q2 filed Aug. 16, 2021
- MWG Management 2021 Q1 filed May 17, 2021
- MWG Management 2020 Q4 filed Feb. 17, 2021